These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11152096)

  • 1. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
    Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses.
    Mathew JM; Fuller L; Carreno M; Garcia-Morales R; Burke GW; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transplantation; 2000 Dec; 70(12):1752-60. PubMed ID: 11152108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cells of donor phenotype present in renal transplant recipients infused with donor marrow: potent regulators of antidonor immune responses of the recipient.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Burke GW; Ciancio G; Carreno M; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    Transplant Proc; 2001; 33(1-2):127-8. PubMed ID: 11266739
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor bone marrow infusion in deceased and living donor renal transplantation.
    Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
    Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation.
    Mathew JM; Carreno M; Fuller L; Ricordi C; Kenyon N; Tzakis AG; Miller J; Esquenazi V
    Transplantation; 1999 Oct; 68(8):1172-80. PubMed ID: 10551647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow.
    Mathes DW; Solari MG; Randolph MA; Gazelle GS; Yamada K; Huang CA; Sachs DH; Lee WP
    Transplantation; 2005 Nov; 80(9):1300-8. PubMed ID: 16314799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation.
    Mathew JM; Carreno M; Fuller L; Burke GW; Ciancio G; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    Transplantation; 2002 Sep; 74(6):846-55. PubMed ID: 12364866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
    Ciancio G; Miller J; Garcia-Morales RO; Carreno M; Burke GW; Roth D; Kupin W; Tzakis AG; Ricordi C; Rosen A; Fuller L; Esquenazi V
    Transplantation; 2001 Apr; 71(7):827-35. PubMed ID: 11349712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
    Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
    Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantation.
    Mathew JM; Carreno M; Zucker K; Fuller L; Kenyon N; Esquenazi V; Ricordi C; Tzakis AG; Miller J
    Transplantation; 1998 Apr; 65(7):947-55. PubMed ID: 9565100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent chimerism despite antidonor MHC in vitro responses in miniature swine following allogeneic hematopoietic cell transplantation.
    Gleit ZL; Cameron AM; Fuchimoto Y; Melendy E; Monajati L; Coburn RC; Sachs DH; Huang CA
    Transplantation; 2002 Nov; 74(9):1260-6. PubMed ID: 12451263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.
    Mathew JM; Ciancio G; Burke GW; Garcia-Morales RO; Rosen A; Wang E; Gomez CI; Blomberg BB; Fuller L; Esquenazi V; Ricordi C; Miller J
    Hum Immunol; 2010 Jun; 71(6):566-76. PubMed ID: 20153397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses.
    Mathew JM; Blomberg B; Fuller L; Burke GW; Ciancio G; Kenyon N; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    J Immunol Methods; 2003 Jan; 272(1-2):67-80. PubMed ID: 12505713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.